| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.4 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.4 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.4 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.4 |